Protalix BioTherapeutics (PLX) News Today $1.64 +0.06 (+3.48%) As of 03:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PLX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period HC Wainwright Has Pessimistic View of PLX FY2025 EarningsAugust 22 at 7:41 AM | marketbeat.comWhat is HC Wainwright's Estimate for PLX FY2025 Earnings?August 22 at 2:01 AM | americanbankingnews.comHC Wainwright Has Pessimistic Outlook of PLX Q3 EarningsAugust 21 at 6:53 AM | marketbeat.comWhat is HC Wainwright's Forecast for PLX Q3 Earnings?August 21 at 3:02 AM | americanbankingnews.comConnor Clark & Lunn Investment Management Ltd. Acquires New Stake in Protalix BioTherapeutics, Inc. (NYSE:PLX)August 18, 2025 | marketbeat.comPLX: New CFO to Take the ReinsAugust 16, 2025 | finance.yahoo.comProtalix BioTherapeutics, Inc. (AMEX:PLX) Q2 2025 Earnings Call TranscriptAugust 15, 2025 | insidermonkey.comProtalix BioTherapeutics Reports Strong Q2 2025 ResultsAugust 15, 2025 | msn.comProtalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business ResultsAugust 14, 2025 | finanznachrichten.deProtalix BioTherapeutics, Inc. (NYSE:PLX) Director Aharon Schwartz Acquires 129,000 SharesAugust 14, 2025 | marketbeat.comProtalix BioTherapeutics, Inc. (PLX) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comProtalix BioTherapeutics lifts revenue on strong Elfabrio demandAugust 14, 2025 | proactiveinvestors.comProtalix BioTherapeutics Reports Second Quarter 2025 Financial and Business ResultsAugust 14, 2025 | prnewswire.comProtalix BioTherapeutics, Inc. (NYSE:PLX) Director Aharon Schwartz Buys 129,000 SharesAugust 13, 2025 | insidertrades.comProtalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025August 7, 2025 | prnewswire.comProtalix Lawsuit Dismissed After Bylaws AmendmentAugust 1, 2025 | tipranks.comProtalix BioTherapeutics Names Gilad Mamlok Chief Financial OfficerJuly 21, 2025 | marketwatch.comProtalix Biotherapeutics Inc.: Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial OfficerJuly 21, 2025 | finanznachrichten.deProtalix BioTherapeutics welcomes new finance chiefJuly 21, 2025 | proactiveinvestors.comPLX | Protalix BioTherapeutics Inc. Annual Cash Flow Statement ...July 10, 2025 | marketwatch.comProtalix BioTherapeutics (NYSE:PLX) Shares Up 3.4% - Still a Buy?July 10, 2025 | marketbeat.comProtalix BioTherapeutics joins Russell 3000 and 2000 indexes following annual reconstitutionJune 30, 2025 | proactiveinvestors.comNorthern Trust Corp Has $1.38 Million Stock Position in Protalix BioTherapeutics, Inc. (NYSE:PLX)May 29, 2025 | marketbeat.comQ1 Earnings Estimate for PLX Issued By HC WainwrightMay 27, 2025 | marketbeat.comProtalix BioTherapeutics (NYSE:PLX) Rating Lowered to Buy at StockNews.comMay 14, 2025 | marketbeat.comProtalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYCMay 14, 2025 | finance.yahoo.comPLX: First Quarter ResultsMay 13, 2025 | msn.comProtalix BioTherapeutics (NYSE:PLX) Issues Earnings ResultsMay 11, 2025 | marketbeat.comEarnings call transcript: Protalix Q1 2025 results miss forecasts, stock plungesMay 10, 2025 | uk.investing.comProtalix BioTherapeutics, Inc. (AMEX:PLX) Q1 2025 Earnings Call TranscriptMay 10, 2025 | insidermonkey.comProtalix BioTherapeutics, Inc.: Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business ResultsMay 10, 2025 | finanznachrichten.deProtalix BioTherapeutics Q1 Earnings PreviewMay 10, 2025 | msn.com1PLX : Uncovering Potential: Protalix BioTherapeutics's Earnings PreviewMay 10, 2025 | benzinga.comProtalix BioTherapeutics, Inc. (PLX) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comProtalix eyes Phase II gout trial later this year following solid Q1 revenue growthMay 9, 2025 | proactiveinvestors.comProtalix BioTherapeutics Reports First Quarter 2025 Financial and Business ResultsMay 9, 2025 | prnewswire.comMarshall Wace LLP Invests $192,000 in Protalix BioTherapeutics, Inc. (NYSE:PLX)May 8, 2025 | marketbeat.comProtalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025May 6, 2025 | seekingalpha.comEquities Analysts Offer Predictions for PLX Q1 EarningsMay 3, 2025 | marketbeat.comRenaissance Technologies LLC Buys 162,100 Shares of Protalix BioTherapeutics, Inc. (NYSE:PLX)April 28, 2025 | marketbeat.comProtalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising PipelineApril 10, 2025 | seekingalpha.comProtalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025March 24, 2025 | finance.yahoo.comIs Protalix BioTherapeutics (PLX) The High Growth Low Debt Stock to Invest in Now?March 22, 2025 | msn.comProtalix Biotherapeutics chairman discusses breakthrough in gout treatment, drug pipeline - ICYMIMarch 21, 2025 | proactiveinvestors.comZacks Small Cap Issues Pessimistic Estimate for PLX EarningsMarch 21, 2025 | marketbeat.comProtalix Stock (PLX) Grabbing Attention with Record Revenue SurgeMarch 20, 2025 | markets.businessinsider.comProtalix BioTherapeutics (NYSE:PLX) Stock Rating Lowered by StockNews.comMarch 20, 2025 | marketbeat.comProtalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comEarnings call transcript: Protalix Q4 2024 sees 31% revenue growthMarch 19, 2025 | uk.investing.comAmended: Protalix Annual Earnings FallMarch 19, 2025 | nasdaq.com Get Protalix BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter. Email Address PLX Media Mentions By Week PLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLX News Sentiment▼0.450.54▲Average Medical News Sentiment PLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLX Articles This Week▼101▲PLX Articles Average Week Get Protalix BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Rezolute News Oruka Therapeutics News Solid Biosciences News Kura Oncology News Prime Medicine News Arvinas News Eton Pharmaceuticals News Savara News Palvella Therapeutics News iTeos Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PLX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access